Is VivioMD a scam
Reduced cancer incidence, longer survival, and fewer metastases were also seen with GLP-1 use in patients with endometrial, bladder and prostate cancers, as well as in those with small intestine neoplasms and blood cancers, multiple studies found
Paper Haebel PW, Goldstone D, Katzen F, Beckwith J, Metcalf P
Its titled Emerging Use of BPC-157 in Orthopedic Sports Medicine: A Systematic Review. I happened to stumble upon this by Dan Lorenz on Twitter
Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)